Rakuten Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Rakuten Investment Management's BIIB Position: Q2 2026 in Review
Rakuten Investment Management increased its Biogen (BIIB) stake by 11% in Q2 2026, buying an estimated $444K and bringing the position to 24,097 shares worth $5.22M. The position accounts for 0.02% of the portfolio, ranked #276.
Rakuten Investment Management first reported a position in BIIB in Q4 2023 and has held it in 9 quarters since. The position peaked at $99.1M in Q3 2025. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Rakuten Investment Management held 24,097 shares of Biogen worth $5.22M as of Q2 2026.
- Rakuten Investment Management bought 2,319 Biogen shares in Q2 2026, an estimated $444K.
- Biogen made up 0.02% of Rakuten Investment Management's portfolio in Q2 2026, its #276 holding.
- Rakuten Investment Management first reported a position in Biogen in Q4 2023 and has held it in 9 quarters since.
- Rakuten Investment Management's Biogen position peaked at $99.1M in Q3 2025.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Rakuten Investment Management's 13F filing for Q2 2026, filed 18 Aug 2026.